Putra Agustian Winarno, Indrasari Sagung Rai, Herdini Camelia, Yudistira Danu
Dr. Sardjito General Hospital, Sleman, Yogyakarta, 55281, Indonesia.
Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Nursing, and Public Health Universitas Gadjah Mada, Sleman, Yogyakarta, 55281, Indonesia.
F1000Res. 2024 Dec 24;13:697. doi: 10.12688/f1000research.147233.1. eCollection 2024.
Arteriovenous malformations (AVMs) in the head and neck pose a challenge in their management due to their local aggressiveness and high recurrence risk. This study aimed to analyze literature on head and neck AVM recurrence post-treatment and identify the most effective strategy with a lower recurrence rate.
To analyse existing literature on the recurrence of head and neck AVMs following treatment. Our goal was to identify the most effective treatment option with a lower recurrence rate.
We conducted a thorough literature search using PubMed, ScienceDirect, and Scopus, from year 2000 to the present. Our analysis focused on key endpoints, specifically the recurrence rates of head and neck AVMs following various treatment approaches.
Out of the initial pool of 108 screened articles, a total of 83 patients were deemed suitable for inclusion in the literature review. The reviewed articles demonstrated that appropriate diagnostic tests were documented in 95% of the included studies. Among the patients, 37.3% had previously undergone interventions and were currently dealing with regrowth masses. Notably, 55.4% of patients underwent a combined approach involving both endovascular and surgical methods, while 25.3% opted for a surgical-only approach, and only 19.3% pursued an endovascular-only approach. The studies showed a promising curing rate of AVMs, with a success rate of 94%, albeit with a complication rate of 32.5%. The average follow-up duration for all patients was 26 months, with a standard deviation of 20.5 months. Out of the 83 patients, 5 experienced recurrence, with single-modality approach. Interestingly, no patients who received a multi-modality of treatments experienced recurrence or regrowth of the AVM mass within the follow up period.
The multi-modality approach outperformed single-modality treatments in preventing AVM recurrence. These findings highlight the importance of a comprehensive and multidisciplinary approach in the management of these complex vascular anomalies.PROSPERO: CRD42023490871 registered on 17/12/2023.
头颈部动静脉畸形（AVM）因其局部侵袭性和高复发风险，在治疗方面具有挑战性。本研究旨在分析头颈部AVM治疗后复发的文献，并确定复发率较低的最有效策略。
分析现有关于头颈部AVM治疗后复发的文献。我们的目标是确定复发率较低的最有效治疗方案。
我们使用PubMed、ScienceDirect和Scopus进行了全面的文献检索，时间跨度从2000年至今。我们的分析重点是关键终点，特别是各种治疗方法后头颈部AVM的复发率。
在初步筛选的108篇文章中，共有83例患者被认为适合纳入文献综述。综述文章表明，95%的纳入研究记录了适当的诊断测试。在这些患者中，37.3%曾接受过干预，目前正在处理复发肿块。值得注意的是，55.4%的患者采用了血管内和手术相结合的方法，25.3%选择了单纯手术方法，只有19.3%采用了单纯血管内方法。研究显示AVM的治愈率很有前景，成功率为94%，尽管并发症发生率为32.5%。所有患者的平均随访时间为26个月，标准差为20.5个月。在83例患者中，5例采用单一治疗方法后复发。有趣的是，在随访期内，接受多模式治疗的患者没有出现AVM肿块复发或再生长的情况。
在预防AVM复发方面，多模式方法优于单一治疗方法。这些发现凸显了综合多学科方法在管理这些复杂血管异常中的重要性。
国际前瞻性系统评价注册库（PROSPERO）：CRD42023490871，于2023年
12月17日注册。
